Five-year overall survival after laparoscopic distal gastrectomy for locally advanced gastric cancer is on par with that of open surgery, according to new data from the Chinese CLASS-01 trial.

Adaptive immune resistance in gastro-esophageal cancer: Correlating tumoral/stromal PDL1 expression with CD8+ cell count. Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric ...

Peripheral natural killer cells are a prognostic factor in advanced oesogastric adenocarcinoma and are associated with intestinal types in the randomized trial PRODIGE17-ACCORD20 (UNICANCER GI). This ...

Please provide your email address to receive an email when new articles are posted on . No significant difference in 5-year relapse-free and overall survival between laparoscopic and open gastrectomy ...

Please provide your email address to receive an email when new articles are posted on . “Open gastrectomy has long been the criterion standard worldwide. However, application of laparoscopic ...

Relapse-free survival (RFS) data at 5 years showed that laparoscopy-assisted distal gastrectomy (LADG) was noninferior to open distal gastrectomy (ODG) in locally advanced gastric cancer, according to ...

Laparoscopic surgery is not easily performed by junior surgeons who have limited experience. To investigate the safety and feasibility of the first experience of junior surgeons with laparoscopic ...

The stomach is a muscular J-shaped sac-like structure, mainly acts as reservoir for the food, located in the upper and left part of abdomen and a crucial part of the digestive organ of ...

Robotic total gastrectomy for gastric cancer is associated with fewer complications than a conventional laparoscopic approach, according to a retrospective comparative analysis conducted at a single ...

Over 95% of gastric cancers originate from the cells of the stomach lining (adenocarcinoma). This guidance applies only to adenocarcinoma. Symptoms may include heartburn, dysphagia and weight loss.